Gilead Sciences (GILD) Ownership

GILD$168.08+0.13 +0.08%
Drug Manufacturers - GeneralMega Cap
Compare
Market cap$208.48BEnterprise value$236.14BRevenue (TTM)$30.99BMarket positionTop 5%

Score

37
Bearish
Value
30
Quality
44
Growth
38

Ownership data loads after the page opens.

Gilead Sciences (GILD) Ownership

GILD price $168.08 +0.13 +0.08%

Ticker
GILD
Price
$168.08
Change
+0.13 +0.08%
Market cap
$208.48B
Forward P/E
19.65
Dividend yield
1.86%
Beta
0.36
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
37
Value
30
Quality
44
Growth
38

Stocklytics score rationale: value 30, quality 44, growth 38.

AI Score 45. Gilead Sciences, Inc. has a market cap of $211.6 billion but is facing significant profitability challenges, with a net profit margin of -0.1247 and a price-to-earnings ratio of -55.1

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener